{"id":2323,"date":"2016-10-11T00:00:00","date_gmt":"2016-10-11T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.comindex.php\/2016\/10\/11\/pinup101116\/"},"modified":"2019-02-06T02:14:51","modified_gmt":"2019-02-06T02:14:51","slug":"pinup101116","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/","title":{"rendered":"PinUp: Pharma Social Check-Up, IoT Pillbox, Payments to Derms, Drug Price Pipeline, No Free Vaccines, More&#8230;"},"content":{"rendered":"<p><b>Pharma Industry News Update<\/b>: 11 October 2016<\/p>\n<hr\/>\n<p>        Pharma Use of Social Media: Not Very Engaging &amp; Not Mostly for Patients<\/p>\n<p>                        <img decoding=\"async\" vspace=\"0\" border=\"0\" hspace=\"0\" style=\"display: block; height: auto !important;\" width=\"550\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2016\/10\/PharmaPosts-v-EngagementChart.jpg\"\/>                          <br \/>The latest Social Check-up by Ogilvy Healthworld, part of Ogilvy CommonHealth, show that Boehringer Ingelheim and Novo Nordisk ranked at the top with the highest social media engagement numbers, while Allergan, Teva, Takeda, Gilead and Astellas all ranked pretty closely together among those with the lowest engagement.<\/p>\n<p>As far as what those posts contained, Ogilvy CommonHealth found that 29% were about disease awareness, followed by 25% company news, 19% around meetings and events, 13% corporate social responsibility, 8% product and research updates, 2% pharma industry news with the remaining 3% other topics.  <\/p>\n<p><a href=\"http:\/\/sco.lt\/8Gv973\" shape=\"rect\" styleclass=\" style_MainLink\" style=\"font-size: 10pt; font-family: Arial; color: #09a3ba; text-decoration: none;\">More here&#8230;<\/a><\/p>\n<p>Also read: &#8220;<a href=\"http:\/\/sco.lt\/7LZYSP\">Many Social Media Marketers Agree That Measuring Engagement Matters to Bottom Line<\/a>&#8221;          <\/p>\n<hr\/>\n<p>        <img loading=\"lazy\" decoding=\"async\" height=\"1\" vspace=\"0\" border=\"0\" hspace=\"0\" width=\"5\" class=\"SpacerImage\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2019\/02\/S.gif\"\/>                              <img decoding=\"async\" vspace=\"0\" border=\"0\" hspace=\"0\" style=\"display: block; height: auto !important;\" width=\"300\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2016\/10\/ElliGrid-Takeda.jpg\"\/>                          Takeda Thinks Outside the Pillbox &amp; Awards $35K to Digital Startup App for Depression<\/p>\n<p>A smart pillbox and companion app recently won Takeda Pharmaceutical&#8217;s crowdsourcing challenge in a &#8220;Shark Tank&#8221;-style showdown of digital depression innovations.<\/p>\n<p>The pharma partnered with MedStartr, a healthcare crowdsourcing and funding site, to gather digital submissions that would address the complex issue of depression and patient needs outside the doctor&#8217;s office. The competition was narrowed down to five finalists who took center stage to present at the Health 2.0 conference, where they were judged by a panel of experts. The winner was EllieGrid, which came up with a combination smart pillbox and companion digital reminder app that notifies both user and caregiver that a dose was taken.         <br \/><a href=\"http:\/\/sco.lt\/4tXAzx\">More here&#8230;<\/a><\/p>\n<p>One of the Japanese drugmaker&#8217;s competitors, Pfizer &#8211; which makes the depression treatment Zoloft &#8211; launched an app called Moodivator, which is also a digital tool to track depression symptoms and feelings. For more about that, read &#8220;<a href=\"http:\/\/sco.lt\/5ejtmT\">Depressed? Pfizer Has an App (&amp; Drug &#8211; Pristiq) for That!<\/a>&#8221;          <\/p>\n<hr\/>\n<p>        Dermatologists Accepted $34 Million from Pharma Companies<\/p>\n<p>                        <img decoding=\"async\" vspace=\"0\" border=\"0\" hspace=\"0\" style=\"display: block; height: auto !important;\" width=\"550\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2016\/10\/PaymentsMade-to-Derms2014.jpg\"\/>                          <br \/>Dermatologists received more than $34 million from industry in 2014, and most of that money came from pharmaceutical companies, according to a new study published in JAMA Dermatology.<\/p>\n<p>In 2014, the first full year of financial data from the Centers for Medicare and Medicaid Services Sunshine Act Open Payment database\u2019s, reveal that 8,333 dermatologists received more than 208,000 payments. The top 10% of dermatologists received 90% of the total payments.<\/p>\n<p>Most of the payments were for food and beverage, but that\u2019s not where the big money was spent.  <\/p>\n<p><a href=\"http:\/\/sco.lt\/6Nojc9\" shape=\"rect\" styleclass=\" style_MainLink\" style=\"font-size: 10pt; font-family: Arial; color: #09a3ba; text-decoration: none;\">More here&#8230;<\/a><\/p>\n<p>Also read: &#8220;<a href=\"http:\/\/sco.lt\/5wQtKj\">Street Prices of Rx Brand-Name Dermatology Drugs Increase as Much as 400%!<\/a>&#8221; Coincidence?          <\/p>\n<hr\/>\n<p>        Doctors Without Borders to Pfizer: We Don&#8217;t Want Your &#8220;Free&#8221; Vaccines. We Want Lower Prices!<\/p>\n<p>                        <img decoding=\"async\" vspace=\"0\" border=\"0\" hspace=\"0\" style=\"display: block; height: auto !important;\" width=\"550\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2016\/10\/NoFreeVaccines.jpg\"\/>                          <br \/>Doctors Without Borders &#8211; M\u00e9decins Sans Fronti\u00e8res (MSF) &#8211; is rejecting the Pfizer&#8217;s offer to donate a significant number of pneumonia vaccine (PCV) doses for the children we serve.<\/p>\n<p>Free is not always better. Donations often involve numerous conditions and strings attached, including restrictions on which patient populations and what geographic areas are allowed to receive the benefits.<\/p>\n<p>Donations are often used as a way to make others &#8220;pay up.&#8221; By giving the pneumonia vaccine away for free, pharmaceutical corporations can use this as justification for why prices remain high for others, including other humanitarian organizations and developing countries that also can&#8217;t afford the vaccine.<\/p>\n<p><a href=\"http:\/\/sco.lt\/5qcfGT\" shape=\"rect\" styleclass=\" style_MainLink\" style=\"font-size: 10pt; font-family: Arial; color: #09a3ba; text-decoration: none;\">More here&#8230;<\/a><br \/>Probable response from Ian Read:<br \/><img decoding=\"async\" vspace=\"0\" border=\"0\" hspace=\"0\" style=\"display: block; height: auto !important;\" width=\"300\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2016\/10\/IanRead-PishTalk-Meme.jpg\"\/>          <\/p>\n<hr\/>\n<p>        Tracking Who Makes Money On A Brand-Name Drug<\/p>\n<p>                        <img decoding=\"async\" vspace=\"0\" border=\"0\" hspace=\"0\" style=\"display: block; height: auto !important;\" width=\"550\" src=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2016\/10\/Pipeline-to-Profits.jpg\"\/>                          <br \/><i>Kaiser Health News<\/i> joined forces with <i>USA Today<\/i> to create this chart, which details the various industry players and how they contribute to a prescription drug\u2019s cost.<\/p>\n<p><a href=\"http:\/\/sco.lt\/7h31Ht\" shape=\"rect\" styleclass=\" style_MainLink\" style=\"font-size: 10pt; font-family: Arial; color: #09a3ba; text-decoration: none;\">See the entire chart here&#8230;<\/a> <\/p>\n<p>No matter what the &#8220;middlemen&#8221; make, drug price INCREASES start at the top; i.e., the drug company.          <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Welcome to the October 11, 2016, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.<\/p>\n","protected":false},"author":2,"featured_media":3022,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[15],"tags":[],"topic":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>PinUp: Pharma Social Check-Up, IoT Pillbox, Payments to Derms, Drug Price Pipeline, No Free Vaccines, More... - Pharma Marketing Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PinUp: Pharma Social Check-Up, IoT Pillbox, Payments to Derms, Drug Price Pipeline, No Free Vaccines, More... - Pharma Marketing Network\" \/>\n<meta property=\"og:description\" content=\"Welcome to the October 11, 2016, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.\" \/>\n<meta property=\"og:url\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Marketing Network\" \/>\n<meta property=\"article:published_time\" content=\"2016-10-11T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-02-06T02:14:51+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2016\/10\/Pipeline-to-Profits.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"550\" \/>\n\t<meta property=\"og:image:height\" content=\"511\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pharma Guy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pharma Guy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/\",\"name\":\"PinUp: Pharma Social Check-Up, IoT Pillbox, Payments to Derms, Drug Price Pipeline, No Free Vaccines, More... - Pharma Marketing Network\",\"isPartOf\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\"},\"datePublished\":\"2016-10-11T00:00:00+00:00\",\"dateModified\":\"2019-02-06T02:14:51+00:00\",\"author\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\"},\"breadcrumb\":{\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PinUp: Pharma Social Check-Up, IoT Pillbox, Payments to Derms, Drug Price Pipeline, No Free Vaccines, More&#8230;\"}]},{\"@type\":\"WebSite\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/\",\"name\":\"Pharma Marketing Network\",\"description\":\"Pharma Marketing Network\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1\",\"name\":\"Pharma Guy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/\",\"url\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"contentUrl\":\"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g\",\"caption\":\"Pharma Guy\"},\"description\":\"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.\",\"url\":\"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PinUp: Pharma Social Check-Up, IoT Pillbox, Payments to Derms, Drug Price Pipeline, No Free Vaccines, More... - Pharma Marketing Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/","og_locale":"en_US","og_type":"article","og_title":"PinUp: Pharma Social Check-Up, IoT Pillbox, Payments to Derms, Drug Price Pipeline, No Free Vaccines, More... - Pharma Marketing Network","og_description":"Welcome to the October 11, 2016, issue of Pharma Industry News Update (aka PinUp). PinUp is published every Tuesday and Friday as part of your Pharma Marketing News subscription service. It features curated pharma industry news and views of topical interest from a variety of sources.","og_url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/","og_site_name":"Pharma Marketing Network","article_published_time":"2016-10-11T00:00:00+00:00","article_modified_time":"2019-02-06T02:14:51+00:00","og_image":[{"width":550,"height":511,"url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-content\/uploads\/2016\/10\/Pipeline-to-Profits.jpg","type":"image\/jpeg"}],"author":"Pharma Guy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pharma Guy","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/","name":"PinUp: Pharma Social Check-Up, IoT Pillbox, Payments to Derms, Drug Price Pipeline, No Free Vaccines, More... - Pharma Marketing Network","isPartOf":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website"},"datePublished":"2016-10-11T00:00:00+00:00","dateModified":"2019-02-06T02:14:51+00:00","author":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1"},"breadcrumb":{"@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/"]}]},{"@type":"BreadcrumbList","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup101116\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/"},{"@type":"ListItem","position":2,"name":"PinUp: Pharma Social Check-Up, IoT Pillbox, Payments to Derms, Drug Price Pipeline, No Free Vaccines, More&#8230;"}]},{"@type":"WebSite","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#website","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/","name":"Pharma Marketing Network","description":"Pharma Marketing Network","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/763fc249c59c91ce203db612d81a75a1","name":"Pharma Guy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/#\/schema\/person\/image\/","url":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","contentUrl":"http:\/\/2.gravatar.com\/avatar\/87853617a5e31233716811d09cdefdf7?s=96&d=identicon&r=g","caption":"Pharma Guy"},"description":"Pharmaguy\u2122 is a \u201cconstructive critic\u201d of pharma marketing and publishes commentary on the Pharma Marketing Blog and on Scoop.it.","url":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/author\/ehs-pharmaguy\/"}]}},"_links":{"self":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/2323"}],"collection":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/comments?post=2323"}],"version-history":[{"count":1,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/2323\/revisions"}],"predecessor-version":[{"id":3023,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/posts\/2323\/revisions\/3023"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media\/3022"}],"wp:attachment":[{"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/media?parent=2323"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/categories?post=2323"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/tags?post=2323"},{"taxonomy":"topic","embeddable":true,"href":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/wp-json\/wp\/v2\/topic?post=2323"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}